Principal Investigator
Warren Alperstein
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20250315
Clinical Trial Summary
A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy with Immuno-oncology Therapy for Children and Adults with Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma
Phase
Phase III
Funding Agency/Sponsor
National Cooperative Group
Disease
Pediatric Cancer
Contact Information
Phone Number
305-243-2647